MUSCULAR ATROPHY, SPINAL

Clinical trials for MUSCULAR ATROPHY, SPINAL explained in plain language.

Never miss a new study

Get alerted when new MUSCULAR ATROPHY, SPINAL trials appear

Sign up with your email to follow new studies for MUSCULAR ATROPHY, SPINAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 3 Completed 6

Double-Duty treatment: new drug aims to boost effects of SMA gene therapy in infants

Disease control Not yet recruiting

This study is testing whether adding a drug called salanersen can improve outcomes for babies with spinal muscular atrophy (SMA) who have already received a one-time gene therapy. Researchers want to see if this follow-up treatment is safe and if it helps babies gain more movemen…

Matched conditions: MUSCULAR ATROPHY, SPINAL

Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

MUSCULAR ATROPHY, SPINAL

Get alerted when new MUSCULAR ATROPHY, SPINAL trials appear

Double-Duty treatment: new drug aims to boost effects of SMA gene therapy in infants